NATIONWIDE RECALL OF BLOOD PRESSURE MEDICATIONS FOLLOWS QUALITY TEST FAILURE
Assistant to President Donald Trump Jarrod Agen discusses the administration’s energy policies and the president’s efforts to rally voters ahead of Election Day on ‘The Evening Edit.’.
Americans who take medication for high blood pressure may want to check their medicine cabinets after thousands of bottles of a prescription drug were recalled nationwide.
New Jersey-based Macleods Pharma USA is recalling certain lots of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets after the medication failed to meet federal quality standards, according to the U.S. Food and Drug Administration (FDA).
The recall covers 3,528 30-count bottles from lot 12251163A and 216 90-count bottles from lot 12251163B. Both lots expire May 31, 2027.
The FDA listed the reason for the recall as “failed dissolution specifications,” meaning the pills did not dissolve as required during testing.
Chlorthalidone is used to treat high blood pressure and fluid retention, according to Mayo Clinic.
Macleods Pharma USA could not immediately be reached by FOX Business for comment.
FOX Business’ Matthew Kazin contributed to this report.
Also Read
- Allison Ellsworth Unveils Jetty, a Fresh Everyday Hydration Brand After Poppi Sale
- Supreme Court Declines Trump Administration Bid to Exclude 20,000 California Ballots Ahead of Midterm Elections
- Midterm Elections Hedge Toward Strong Market Performance: Historical S&P 500 Insights
- Trump’s Approval Rating Reaches Near-Record Low as US Midterms Approach